ERYTHROPOIETIN - A CANDIDATE TREATMENT FOR MOOD SYMPTOMS AND COGNITIVE DYSFUNCTION IN DEPRESSION

ERYTHROPOIETIN - A CANDIDATE TREATMENT FOR MOOD SYMPTOMS AND COGNITIVE DYSFUNCTION IN DEPRESSION

Opis bibliograficzny
Główni autorzy:	Miskowiak, K, Vinberg, M, Harmer, C, Ehrenreich, H, Kessing, L
Format:	Conference item
Wydane:	2011

Podobne zapisy

Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression.
od: Miskowiak, K, i wsp.
Wydane: (2012)

Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder.
od: Miskowiak, K, i wsp.
Wydane: (2010)

Neural correlates of improved executive function following erythropoietin treatment in mood disorders
od: Miskowiak, K, i wsp.
Wydane: (2016)

Effects of erythropoietin on memory-relevant neurocircuitry activity and recall in mood disorders.
od: Miskowiak, K, i wsp.
Wydane: (2016)

Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder
od: Paulson Olaf B, i wsp.
Wydane: (2010-10-01)

Neural correlates of improved recognition of happy faces after erythropoietin treatment in bipolar disorder
od: Miskowiak, K, i wsp.
Wydane: (2018)

Erythropoietin as candidate for supportive treatment of severe COVID-19
od: Hannelore Ehrenreich, i wsp.
Wydane: (2020-06-01)

Erythropoietin improves mood and modulates the cognitive and neural processing of emotion 3 days post administration.
od: Miskowiak, K, i wsp.
Wydane: (2008)

Effects of recombinant human erythropoietin on cognition and neural activity in remitted patients with mood disorders and first-degree relatives of patients with psychiatric disorders: a study protocol for a randomized controlled trial
od: Jeff Zarp Petersen, i wsp.
Wydane: (2018-11-01)

Whole-Brain Exploratory Analysis of Functional Task Response Following Erythropoietin Treatment in Mood Disorders: A Supervised Machine Learning Approach
od: Søren F. V. Nielsen, i wsp.
Wydane: (2019-11-01)

Neural and Behavioral Predictors of Treatment Efficacy on Mood Symptoms and Cognition in Mood Disorders: A Systematic Review
od: Ida Seeberg, i wsp.
Wydane: (2018-07-01)

Is negative self-referent bias an endophenotype for depression? An fMRI study of emotional self-referent words in twins at high vs. low risk of depression
od: Miskowiak, K, i wsp.
Wydane: (2017)

The effect of recombinant erythropoietin on plasma brain derived neurotrophic factor levels in patients with affective disorders: a randomised controlled study.
od: Maj Vinberg, i wsp.
Wydane: (2015-01-01)

Differences in neural and cognitive response to emotional faces in middle-aged dizygotic twins at familial risk of depression
od: Miskowiak, K, i wsp.
Wydane: (2017)

Effects of Short-Term Cognitive Remediation on Cognitive Dysfunction in Partially or Fully Remitted Individuals with Bipolar Disorder: Results of a Randomised Controlled Trial.
od: Kirsa M Demant, i wsp.
Wydane: (2015-01-01)

Is aberrant affective cognition an endophenotype for affective disorders? A monozygotic twin study
od: Meluken, I, i wsp.
Wydane: (2018)

Erythropoietin as an add-on treatment for cognitive side effects of electroconvulsive therapy: a study protocol for a randomized controlled trial
od: Lejla Sjanic Schmidt, i wsp.
Wydane: (2018-04-01)

Erythropoietin reduces neural and cognitive processing of fear in human models of antidepressant drug action.
od: Miskowiak, K, i wsp.
Wydane: (2007)

Erythropoietin modulates neural and cognitive processing of emotional information in biomarker models of antidepressant drug action in depressed patients.
od: Miskowiak, K, i wsp.
Wydane: (2010)

Aberrant cognition in newly diagnosed patients with bipolar disorder and their unaffected relatives
od: Kjaerstad, H, i wsp.
Wydane: (2019)

Does Cognitive Dysfunction in Bipolar Disorder Qualify as a Diagnostic Intermediate Phenotype?—A Perspective Paper
od: Lars Vedel Kessing, i wsp.
Wydane: (2018-10-01)

Erythropoietin enhances hippocampal response during memory retrieval in humans.
od: Miskowiak, K, i wsp.
Wydane: (2007)

Erythropoietin modulates emotional processing in biomarker models of antidepressant drug action in depressed patients
od: Miskowiak, K, i wsp.
Wydane: (2009)

Erythropoietin modulates emotional processing in biomarker models of antidepressant drug action in depressed patients
od: Miskowiak, K, i wsp.
Wydane: (2009)

Effects of erythropoietin on emotional processing biases in patients with major depression: an exploratory fMRI study.
od: Miskowiak, K, i wsp.
Wydane: (2009)

Differential effects of erythropoietin on neural and cognitive measures of executive function 3 and 7 days post-administration.
od: Miskowiak, K, i wsp.
Wydane: (2008)

Erythropoietin improves operant conditioning and stability of cognitive performance in mice
od: Ehrenreich Hannelore, i wsp.
Wydane: (2009-07-01)

Editorial: Cognition in Mood Disorders
od: Mayowa Oyesanya, i wsp.
Wydane: (2020-01-01)

Predictors of mood and activity instability in participants with newly diagnosed bipolar disorder – Exploratory findings from a prospective cohort study
od: Anton Julius von Hofacker, i wsp.
Wydane: (2024-01-01)

The role of dysfunctional attitudes in depressive mood and the mediation effect of "hot" evaluative cognitions
od: Marić Zorica
Wydane: (2003-01-01)

Effects of cognitive training under hypoxia on cognitive proficiency and neuroplasticity in remitted patients with mood disorders and healthy individuals: ALTIBRAIN study protocol for a randomized controlled trial
od: Kamilla Woznica Miskowiak, i wsp.
Wydane: (2024-10-01)

Erythropoietin ameliorates diabetes-associated cognitive dysfunction in vitro and in vivo
od: Meng Wang, i wsp.
Wydane: (2017-06-01)

Improving Mood and Cognitive Symptoms in Huntington's Disease With Cariprazine Treatment
od: Maria Judit Molnar, i wsp.
Wydane: (2022-02-01)

COGNITIVE MEDIATION OF DEPRESSED MOOD AND NEUROTICISM
od: Martin, M, i wsp.
Wydane: (1985)

Cognitive emotional processing across mood disorders
od: Panchal, P, i wsp.
Wydane: (2019)

Effect of action-based cognitive remediation on cognition and neural activity in bipolar disorder: study protocol for a randomized controlled trial
od: Caroline V. Ott, i wsp.
Wydane: (2018-09-01)

Mood and Activity Measured Using Smartphones in Unipolar Depressive Disorder
od: Morten Lindbjerg Tønning, i wsp.
Wydane: (2021-07-01)

Correction to: Effect of action-based cognitive remediation on cognition and neural activity in bipolar disorder: study protocol for a randomized controlled trial
od: Caroline V. Ott, i wsp.
Wydane: (2019-04-01)

Erythropoietin re-wires cognition-associated transcriptional networks
od: Manvendra Singh, i wsp.
Wydane: (2023-08-01)

Relation between habitual sleep duration and depressed mood state: Somatic versus cognitive symptoms
od: Gualberto Buela-Casal, i wsp.
Wydane: (2007-01-01)